Skip to Main Content

Author Details

Young Do Kwon
1997
60
39
PMIDPaper TitleJournal TitlePublished Year
36729903Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency.MAbs2023
36411391A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins.Nat Chem Biol2023
37605043Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization.Nat Struct Mol Biol2023
37345226Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain.2023
36555641Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists.2022
35677079Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins.bioRxiv2022
35413243Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site.Structure2022
34328065A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention.mAbs2021
34200826Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography.Antibodies (Basel)2021
33827946Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.Journal of Virology2021
32561362The covalent SNAP tag for protein display quantification and low-pH protein engineering.J Biotechnol2020
32348769HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies.Cell Rep2020
31348886Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.Cell2019
30876875Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.Immunity2019
31473167Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.Lancet HIV,The2019
29444432Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody.Cell Rep2018
29867235Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.Nat Med2018
29860061Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.European Journal of Medicinal Chemistry2018
28266845Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.Journal of Medicinal Chemistry2017
28445724Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.Cell Rep2017
28931639Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.Science2017
28517931Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.Journal of Medicinal Chemistry2017
29212041Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.Cell Reports2017
26949186Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.Cell2016
27114034Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.Cell2016
27053554Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.J Virol2016
26301736Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.Journal of Medicinal Chemistry2015
25800131Eliminating antibody polyreactivity through addition of N-linked glycosylation.Protein Science2015
25865483Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection.Cell2015
26098315Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env.Nat Struct Mol Biol2015
25001301Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.Antimicrobial Agents and Chemotherapy2014
24489681Crystal structures of HIV-1 gp120 envelope glycoprotein in complex with NBD analogues that target the CD4-binding site.PLoS ONE2014
25142607Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.J Virol2014
25165110Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.Journal of Virology2014
23707685Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 ÿ cocrystal structure of gp120 and M48U1.Structure2013
23911655Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies.Immunity2013
23843642Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains.Journal of Virology2013
23661761Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.Science2013
22142236Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells.2012
22497421Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors.Journal of Medicinal Chemistry2012
22524483Design, synthesis, and antiviral activity of entry inhibitors that target the CD4-binding site of HIV-1.Journal of Medicinal Chemistry2012
22451932Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops.Proc Natl Acad Sci U S A2012
23107345Effects of corticosteroid on the expressions of neuropeptide and cytokine mRNA and on tenocyte viability in lateral epicondylitis.Journal of Inflammation2012
22113616Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.Nature2011
21169023Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening.Bioorganic and Medicinal Chemistry2011
20690185Interleukin-1β induces angiogenesis and innervation in human intervertebral disc degeneration.Journal of Orthopaedic Research2011
20471426Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells.Journal of Virological Methods2010
20624166Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.Cancer Sci2010
20616231Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.Science2010
20080564Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility.Proceedings of the National Academy of Sciences of the United States of America2010
  • 1 - 50 of 60

Recommended Authors

Collaborators

Co-authored papers 48
Co-authored papers 27
Co-authored papers 21
Co-authored papers 21
Co-authored papers 20
Zuckerman Mind Brain Behaviour Institute
Co-authored papers 19
Co-authored papers 19
Co-authored papers 17
Co-authored papers 17
Co-authored papers 16
Co-authored papers 16
Co-authored papers 14
Co-authored papers 11
Co-authored papers 10
Co-authored papers 9
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4